Search

Your search keyword '"Grebely, Jason"' showing total 1,305 results

Search Constraints

Start Over You searched for: Author "Grebely, Jason" Remove constraint Author: "Grebely, Jason"
1,305 results on '"Grebely, Jason"'

Search Results

2. Impact of simplified HCV diagnostic strategies on the HCV epidemic among men who have sex with men in the era of HIV oral pre‐exposure prophylaxis in Taiwan: a modelling study

5. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: systematic review and meta-analysis

7. Factors associated with experiencing stigma, discrimination, and negative health care treatment among people who inject drugs

9. 96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial

12. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

13. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

14. Health-Related Quality of Life of People Who Inject Drugs: The Enhancing Treatment of Hepatitis C in Opioid Substitution Settings Engage Study

15. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review

17. Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot

19. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

22. Reinfection incidence and risk among people treated for recent hepatitis C virus infection

24. Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs

26. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review

29. Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: The TEMPO Pilot Study

30. Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection

31. Empfehlungen zur Hepatitis Versorgung bei Drogenkonsumierenden

32. Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: A systematic review and meta-analysis

33. Recomendaciones para el manejo de la infección por el virus de la hepatitis C entre usuarios de drogas por vía parenteral

34. Recommandations pour la prise en charge de l’infection par le virus de l’hépatite C chez les usagers de drogues par injection

35. Hepatitis C virus transmission between eight high-income countries among men who have sex with men: a whole-genome analysis

37. Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions

38. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study

39. Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: The ETHOS Engage study

40. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals

41. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

42. Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysis

43. Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

45. Factors associated with hepatitis C treatment uptake among females of childbearing age in New South Wales, Australia: A population‐based study.

46. Health utility among people who regularly use opioids in Australia.

47. Needle and syringe sharing among people who have recently injected drugs in Australia: The ETHOS Engage Study.

48. The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative.

Catalog

Books, media, physical & digital resources